DDS vs. NVO
Compare and contrast key facts about Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DDS or NVO.
Correlation
The correlation between DDS and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DDS vs. NVO - Performance Comparison
Key characteristics
DDS:
0.74
NVO:
-0.92
DDS:
1.26
NVO:
-1.21
DDS:
1.16
NVO:
0.84
DDS:
0.97
NVO:
-0.73
DDS:
2.09
NVO:
-1.65
DDS:
13.95%
NVO:
20.79%
DDS:
39.66%
NVO:
37.29%
DDS:
-93.94%
NVO:
-71.32%
DDS:
-1.55%
NVO:
-46.80%
Fundamentals
DDS:
$7.84B
NVO:
$350.00B
DDS:
$38.76
NVO:
$3.15
DDS:
12.72
NVO:
24.72
DDS:
-1.28
NVO:
1.14
DDS:
$4.51B
NVO:
$290.40B
DDS:
$1.82B
NVO:
$245.88B
DDS:
$637.49M
NVO:
$148.56B
Returns By Period
In the year-to-date period, DDS achieves a 14.22% return, which is significantly higher than NVO's -9.47% return. Over the past 10 years, DDS has outperformed NVO with an annualized return of 17.99%, while NVO has yielded a comparatively lower 15.76% annualized return.
DDS
14.22%
8.87%
47.93%
23.49%
57.04%
17.99%
NVO
-9.47%
-6.09%
-42.27%
-35.34%
21.66%
15.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DDS vs. NVO — Risk-Adjusted Performance Rank
DDS
NVO
DDS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DDS vs. NVO - Dividend Comparison
DDS's dividend yield for the trailing twelve months is around 5.27%, more than NVO's 1.85% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DDS Dillard's, Inc. | 5.27% | 6.02% | 5.18% | 4.89% | 6.41% | 0.95% | 0.68% | 0.66% | 0.57% | 0.45% | 0.40% | 0.19% |
NVO Novo Nordisk A/S | 1.85% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
DDS vs. NVO - Drawdown Comparison
The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.
Volatility
DDS vs. NVO - Volatility Comparison
The current volatility for Dillard's, Inc. (DDS) is 9.41%, while Novo Nordisk A/S (NVO) has a volatility of 13.24%. This indicates that DDS experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DDS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities